Cinclus Pharma Holding AB (publ) (STO:CINPHA)
Sweden · Delayed Price · Currency is SEK 16.90
-1.00 (-5.59%)
At close: Mar 24, 2026
Cinclus Pharma Holding AB Market Cap
Cinclus Pharma Holding AB has a market cap or net worth of 786.49 million as of March 25, 2026. Its market cap has increased by 23.39% in one year.
Market Cap
786.49M
Enterprise Value
307.13M
Revenue
57.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.90
Market Cap Chart
Since June 20, 2024, Cinclus Pharma Holding AB's market cap has decreased from 1.52B to 786.49M, a decrease of -48.17%. That is a compound annual growth rate of -31.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 786.49M | -12.25% |
| Dec 30, 2025 | 896.32M | -9.92% |
| Dec 30, 2024 | 994.98M | -34.43% |
| Jun 20, 2024 | 1.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioGaia AB | 11.33B |
| Cereno Scientific AB | 1.95B |
| EQL Pharma AB | 1.55B |
| Dicot Pharma AB | 844.93M |
| Orexo AB | 788.60M |
| Nanexa AB | 625.42M |
| Enzymatica AB | 553.44M |
| Moberg Pharma AB | 491.16M |